Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Ann R Coll Surg Engl ; 2023 Nov 20.
Article in English | MEDLINE | ID: mdl-37983006

ABSTRACT

Metastatic melanoma of the gallbladder is a rare entity that is often diagnosed late, leading to a poor prognosis. The disease may present insidiously as acute cholecystitis or remain asymptomatic. Optimal management remains unclear but surgical resection is considered the mainstay of treatment for this condition. We report the case of a 47-year-old man who suffered a protracted course of generalised abdominal symptoms eventually culminating in a diagnosis of acute cholecystitis. Following an emergency laparoscopic cholecystectomy, the histology revealed a melanoma with an unknown primary. Subsequently this was traced to the nasopharynx. Because of the presence of concurrent liver metastasis, systemic immunotherapy with palliative intent was commenced following a multidisciplinary team discussion. This case highlights the importance of sending clinical specimens for histological analysis. We argue against selectively choosing which specimens to send for histology because radiological and/or intraoperative macroscopic inspection of resected tissue alone can result in a missed diagnosis.

2.
Brain Res Brain Res Protoc ; 15(2): 79-91, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15905117

ABSTRACT

In our laboratory, we have developed methods in real-time detection and quantitative-polymerase chain reaction (Q-PCR) to analyse the relative levels of gene expression in post mortem brain tissues. We have then applied this method to examine differences in gene activity between normal white matter (NWM) and plaque tissue from multiple sclerosis (MS) patients. Genes were selected based on their association with pathology and through identification by previously conducted global gene expression analysis. Plaque tissue was obtained from secondary progressive (SP) patients displaying chronic active, as well as acute pathologies; while NWM from the same location was obtained from age- and sex-matched controls (normal patients). In this study, we used both SYBR Green I supplementation and commercially available mixes to assess both comparative and absolute levels of gene activity. The results of both methods compared favourably for four of the five genes examined (P < 0.05, Pearsons), while differences in gene expression between chronic active and acute pathologies were also identified. For example, a >50-fold increase in osteopontin (Spp1) and inositol 1-4-5 phosphate 3 kinase B (Itpkb) levels in acute plaques contrasted with the 5-fold or less increase in chronic active plaques (P < 0.05, unpaired t test). By contrast, there was no significant difference in the levels of the MS marker and calcium-dependent protease (Calpain, Capns1) in MS plaque tissue. In summary, Q-PCR analysis using SYBR Green I has allowed us to economically obtain what may be clinically significant information from small amounts of the CNS, providing an opportunity for further clinical investigations.


Subject(s)
Gene Expression Profiling/methods , Multiple Sclerosis/genetics , Multiple Sclerosis/pathology , Polymerase Chain Reaction/methods , Female , Gene Dosage , Gene Expression Profiling/standards , Gene Expression Regulation , Genetic Markers , Humans , Male , Middle Aged , Polymerase Chain Reaction/standards , Postmortem Changes , Reproducibility of Results
3.
J Neuroimmunol ; 78(1-2): 97-107, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9307233

ABSTRACT

The myeloperoxidase enzyme (MPO) is expressed specifically in myeloid cells and catalyzes the formation of hypochlorous acid and other cytotoxic oxidants. We previously reported that two alleles of MPO exist which differ in promoter strength due to a base difference in an Alu-encoded hormone response element. The present study shows that the higher expressing MPO genotype is overrepresented in early onset multiple sclerosis in females, implicating MPO in this demyelinating disease. Contrary to the general conception that macrophages lack MPO, immunohistochemical analysis shows that MPO is present in microglia/macrophages in and around MS lesions as shown by colocalization with major histocompatibility antigens HLA-DR and phagocytized myelin. Also, MPO mRNA sequences are detected in cDNA derived from isolated human adult microglia. This is the first evidence that MPO is present in microglia/macrophages at MS lesions, that MPO gene expression occurs in microglia and that MPO plays a role in MS pathogenesis as shown by the allelic disequilibrium in early onset disease.


Subject(s)
Multiple Sclerosis/enzymology , Peroxidase/physiology , Adult , Aged , DNA, Complementary/genetics , DNA, Complementary/metabolism , Female , Genotype , Humans , Immunohistochemistry , Macrophages/metabolism , Male , Microglia/metabolism , Middle Aged , Multiple Sclerosis/pathology , Peroxidase/genetics , RNA, Messenger/genetics , RNA, Messenger/metabolism
4.
J Med Virol ; 52(3): 301-8, 1997 Jul.
Article in English | MEDLINE | ID: mdl-9210040

ABSTRACT

Human herpesvirus 6 (HHV-6), the etiologic agent of roseola in young children, has been reported to be detectable in the brain of many neurologically normal adults, although regional localization to plaques of multiple sclerosis has also been demonstrated. Large amounts of this virus were present in multifocal demyelinating white matter lesions of fulminant encephalomyelitis with seizures in a 21-year-old woman with normal immune parameters. Brain biopsy after 3 weeks of neurologic deterioration revealed a viral etiology by light and electron microscopy; the virus was identified as HHV-6 by immunohistochemistry and by polymerase chain reaction (PCR) amplification in biopsy and autopsy specimens.


Subject(s)
Brain/virology , Demyelinating Diseases/virology , Encephalomyelitis/virology , Herpesviridae Infections/complications , Herpesvirus 6, Human , Adult , Brain/pathology , Demyelinating Diseases/immunology , Demyelinating Diseases/pathology , Demyelinating Diseases/physiopathology , Encephalomyelitis/immunology , Encephalomyelitis/pathology , Encephalomyelitis/physiopathology , Fatal Outcome , Female , Herpesviridae Infections/immunology , Herpesvirus 6, Human/genetics , Humans , Immunocompetence , Magnetic Resonance Imaging
5.
J Acquir Immune Defic Syndr Hum Retrovirol ; 10(4): 425-35, 1995 Dec 01.
Article in English | MEDLINE | ID: mdl-7583438

ABSTRACT

We quantified HIV-1 RNA levels (copies per milliliter) in cerebrospinal fluid (CSF) and serum from subjects at various stages of HIV-1 disease and determined the relationship of RNA levels to clinical and neurologic disease status (HND) and to laboratory values. Ninety-seven HIV-1-seropositive men without CNS opportunistic infections, tumors, or neurosyphilis and 13 high-risk seronegative controls were included in the study. Each individual underwent a structured interview and physical and neurologic examinations, followed by standardized collection of blood and CSF. A custom-designed, fully automated polymerase chain reaction (PCR) system was used to perform a minimum of four separate amplifications per specimen, using two HIV-1 gag primer pairs. Southern blotting followed by hybridization with product-specific probes was used for post-PCR detection. The number of copies per milliliter was determined by relating unknowns to a built-in dilution-series standard curve using an image analysis system. HIV-1 RNA was detectable in 96% of the sera, 78% of the concentrated CSF samples, and 54% of the unconcentrated CSF samples. Serum RNA levels were significantly higher than in CSF. Serum RNA levels were significantly inversely correlated with CD4+ cell counts (p = -0.34; p = 0.03): i.e., higher RNA levels in seropositive subjects were associated with lower numbers of CD4+ cells. Serum RNA levels correlated positively with number of AIDS-related symptoms, dysfunction scores for total neurological examination, mental status score, cranial nerve score, and CNS motor signs score. Serum RNA levels did not correlate significantly with length of time on zidovudine therapy, intrathecal IgG synthesis rate, or albumin leakage. RNA levels in CSF significantly correlated only with intrathecal IgG synthesis rate and with serum RNA levels. These results confirm that serum levels of HIV-1 RNA correlate with HND and inversely correlate with CD4 counts, demonstrating that HND occurs predominantly in late stages of HIV-1 disease, although HIV-1 RNA can be detected in CSF from a majority of HIV-1-seropositive individuals at all stages of disease, which suggests that there can be early penetration of HIV into the CNS. However, HND can occur in the absence of high levels of CSF HIV-1 RNA. We also found that the concentration of HIV-1 in CSF is correlated with intrathecal IgG synthesis rate.


Subject(s)
AIDS Dementia Complex/diagnosis , HIV Seropositivity/diagnosis , HIV-1/genetics , Polymerase Chain Reaction/methods , RNA, Viral/blood , RNA, Viral/cerebrospinal fluid , AIDS Dementia Complex/blood , AIDS Dementia Complex/cerebrospinal fluid , Adult , Base Sequence , Blotting, Southern , CD4 Lymphocyte Count , CD4-Positive T-Lymphocytes/virology , Cerebrospinal Fluid/virology , DNA Primers/chemistry , Gene Products, gag , HIV Seropositivity/blood , HIV Seropositivity/cerebrospinal fluid , HIV-1/isolation & purification , Humans , Male , Molecular Sequence Data
7.
J Neuropathol Exp Neurol ; 53(6): 572-81, 1994 Nov.
Article in English | MEDLINE | ID: mdl-7964898

ABSTRACT

Retroviral infection of the central nervous system (CNS) causes chronic functional and morphological damage in a wide variety of mammals. Neuropathological studies have focused on subcortical pathology, however, the neocortex is also affected. Because studies of human CNS pathology have been limited to the use of material from terminal stages of disease, we used two neuropathogenic murine leukemia virus (MuLV) models to study the development of neocortical damage. MuLV infection caused spongiform change in the spinal cord, brainstem and cerebellum but not in the cerebrum. However, over the course of disease, we observed a reduction of neocortical thickness, accompanied by diminished neuronal and dendritic spine density. Electron microscopic studies showed minimal to no ultrastructural alterations of dendritic spines. Since there was no evidence of extensive direct viral infection of the neocortical neurons or glia at the ultrastructural level, we hypothesize that neocortical damage may be an indirect effect of subcortical retroviral infection.


Subject(s)
Cerebral Cortex/pathology , Encephalitis/pathology , Retroviridae Infections/pathology , Tumor Virus Infections/pathology , Animals , Cerebral Cortex/ultrastructure , Dendrites/ultrastructure , Mice , Mice, Inbred Strains , Retroviridae
8.
Mol Chem Neuropathol ; 22(3): 143-60, 1994 Aug.
Article in English | MEDLINE | ID: mdl-7993524

ABSTRACT

Mouse models of infection of the central nervous system (CNS) have been used to study retroviral-induced neurologic disease. Ecotropic-neurotropic murine leukemia virus (MuLV) infection of susceptible neonatal mice causes a neurologic disease characterized by progressive hindlimb paralysis. The lesions consist of chronic noninflammatory spongiform change predominantly involving brainstem and spinal cord. Two molecularly cloned strains of MuLV, ts-1, a temperature-sensitive mutant of Moloney MuLV, and pNE-8, derived from a feral mouse isolate Cas-Br-E, were used in this study. Infected mice were sacrificed at regular intervals postinoculation throughout the time-course of disease. The neuropathology was evaluated using standard histological and immunohistopathological techniques. Tissue concentrations of viral proteins and potentially cytotoxic factors were compared with the histopathology in select regions of the CNS. Areas of extensive vacuolation with neuronal and oligodendroglial infection were observed in spinal cord, brainstem, and cerebellum. High titers of infectious virus were observed within CNS lesions, whereas low titers were observed in morphologically uninvolved areas. Western blot analysis revealed abundant production of viral envelope proteins, which correlated well with infectious virus titers. Serum quinolinic acid (QUIN) concentrations in both groups of noninfected and infected mice were similar. However, CNS tissue concentrations of QUIN, TNF alpha, and IL-6 in ts-1 infected mice were significantly higher than in pNE-8 infected or noninfected mice. The difference in concentration of these factors may be the result of greater activation of macrophages/microglia in ts-1 infected mice. During murine retroviral encephalitis, CNS damage may be mediated by direct infection of CNS cells and may be enhanced by indirect effects of neurotoxic factors possibly secreted by infected/activated macrophages.


Subject(s)
Brain/metabolism , Interleukin-6/metabolism , Leukemia Virus, Murine , Nervous System Diseases/virology , Quinolinic Acid/metabolism , Retroviridae Infections/metabolism , Spinal Cord/metabolism , Tumor Necrosis Factor-alpha/metabolism , Animals , Animals, Newborn , Brain/pathology , Brain/virology , Brain Stem/metabolism , Brain Stem/pathology , Brain Stem/virology , Female , Leukemia Virus, Murine/genetics , Leukemia Virus, Murine/isolation & purification , Mice , Mice, Inbred BALB C , Mice, Inbred C3H , Moloney murine leukemia virus/genetics , Mutation , Nervous System Diseases/pathology , Pregnancy , Spinal Cord/pathology , Spinal Cord/virology , Tumor Virus Infections/metabolism , Viral Envelope Proteins/metabolism
9.
J Infect Dis ; 169(3): 623-7, 1994 Mar.
Article in English | MEDLINE | ID: mdl-8158038

ABSTRACT

Cytomegalovirus (CMV) is a common opportunistic pathogen infecting AIDS patients. Polymerase chain reaction (PCR) and antigen capture ELISA were used to detect CMV in 40 cerebrospinal fluid autopsy specimens from patients with AIDS. CMV DNA was detected by PCR in 70% of samples. Of the 21 samples from patients with systemic CMV infection, 57% had CMV encephalitis, while 81% had virus in cerebrospinal fluid detectable by PCR. Of the 24 samples from patients with no histologic evidence of CMV encephalitis, 58% had CMV DNA in cerebrospinal fluid detected by PCR. These results suggest that PCR of cerebrospinal fluid sensitively detects systemic CMV infection but is not specific for brain infection in autopsy specimens of AIDS patients.


Subject(s)
AIDS-Related Opportunistic Infections/cerebrospinal fluid , Cytomegalovirus Infections/cerebrospinal fluid , Cytomegalovirus/isolation & purification , Antigens, Viral/analysis , Autopsy , Base Sequence , Brain/microbiology , Cytomegalovirus Infections/complications , DNA Primers , Humans , Molecular Sequence Data , Polymerase Chain Reaction , Sensitivity and Specificity
10.
Exp Neurol ; 124(2): 283-8, 1993 Dec.
Article in English | MEDLINE | ID: mdl-8287927

ABSTRACT

Central nervous system (CNS) damage occurs during retroviral infection in both man and animals. As a model of human disease, we studied the distribution and extent of CNS damage during retroviral infection with two molecularly cloned, neurotropic murine leukemia viruses. Both viruses mediate a spongiform encephalopathy involving predominantly the brainstem and spinal cord. During the course of disease, immune reactivity for synaptophysin (SYN) (to identify presynaptic elements) and microtubule-associated protein-2 (MAP-2) (to identify postsynaptic elements) were quantified using confocal laser microscopy. Immunostaining of SYN in the cerebral cortex (an area not exhibiting spongiform lesions) was similar in viral infected and age-matched control mice. However, compared to age matched controls, SYN staining in the brainstem (an area exhibiting spongiform lesions) of viral infected mice progressively declined during the course of disease. Quantitative analysis showed greater reduction of MAP-2 immunostaining in viral-infected mice compared to age-matched controls. In infected mice, both regions with and without spongiform lesions showed diminished MAP-2 staining. Widely distributed microscopic vacuolation of dendritic processes was observed in confocal preparations. These findings suggest primary dendritic damage in murine retroviral infection of the CNS similar to what has been described in human immunodeficiency virus-1 encephalitis.


Subject(s)
Brain/pathology , Dendrites/pathology , Encephalitis/pathology , Moloney murine leukemia virus , Retroviridae Infections/pathology , Spinal Cord/pathology , Synapses/pathology , Tumor Virus Infections/pathology , Animals , Animals, Newborn , Brain/ultrastructure , Dendrites/ultrastructure , Female , Glial Fibrillary Acidic Protein/analysis , Humans , Mice , Mice, Inbred BALB C , Mice, Inbred C3H , Mice, Inbred C57BL , Microtubule-Associated Proteins/analysis , Reference Values , Spinal Cord/ultrastructure , Spleen/pathology , Synapses/ultrastructure , Synaptophysin/analysis
11.
J Neuropathol Exp Neurol ; 52(2): 163-73, 1993 Mar.
Article in English | MEDLINE | ID: mdl-8382732

ABSTRACT

Murine leukemia virus infection serves as a model for noninflammatory degeneration of the central nervous system (CNS). During the course of infection with either of the molecularly cloned viruses pNE-8 or ts-1, we observed that ts-1 spread twice as rapidly as pNE-8, and ascended higher in the neuraxis. Endothelial cells were infected first, followed by oligodendrocytes and neurons, while astrocytes containing glial fibrillary acidic protein were not infected. Additionally, ts-1 also infected macrophages/microglia. Major histocompatibility complex (MHC) class I beta 2-microglobulin expression was minimal in pNE-8 infected mice, while it was elevated in endothelial cells of early ts-1 lesions, and in macrophages/microglia during later stages. Occasional infected cells expressed beta 2-microglobulin while rare endothelial and parenchymal cells expressed MHC class II in both viral infections. Limited intra-CNS MHC expression may be one of the mechanisms of viral persistence and will present a barrier to developing immunotherapy for CNS retroviral infections. The few mice that escaped lethal infection had higher serum titers of neutralizing antibodies and showed no neuropathologic changes or detectable virus in the CNS. Higher titers of neutralizing antibodies may protect the CNS from infection.


Subject(s)
Antibodies, Viral/blood , Brain/pathology , Encephalitis/pathology , Leukemia Virus, Murine , Leukemia, Experimental/pathology , Major Histocompatibility Complex , Tumor Virus Infections/pathology , Animals , Animals, Newborn , Antibodies, Viral/biosynthesis , Brain/immunology , Cloning, Molecular , Encephalitis/immunology , Friend murine leukemia virus , Gene Expression , Genes, MHC Class II , Leukemia, Experimental/immunology , Leukemia, Experimental/microbiology , Macrophages/pathology , Mice , Mice, Inbred BALB C , Mice, Inbred C3H , Moloney murine leukemia virus , Neoplasm Staging , Neutralization Tests , Tumor Virus Infections/immunology , beta 2-Microglobulin/biosynthesis , beta 2-Microglobulin/genetics
12.
Lab Invest ; 66(3): 292-302, 1992 Mar.
Article in English | MEDLINE | ID: mdl-1311397

ABSTRACT

The Cas-Br-E strain of murine leukemia virus is a neurovirulent retrovirus that induces progressive noninflammatory degeneration of the central nervous system (CNS). The molecular clone pNE-8 retains pathogenic properties of Cas-Br-E. The neurotropic determinants are known; however, the mechanism of neuropathogenesis is unknown. We examined the temporal development of disease after infection of SWR/J mice with pNE-8 virus. Development of CNS lesions, cellular targets of viral replication, accumulation of ubiquitinated proteins and integrity of blood-brain barrier were determined in mice infected with pNE-8 virus; and compared with uninfected, sham-infected, and nonneuropathogenic virus-infected mice. During 24 weeks of pNE-8 infection, noninflammatory spongiform lesions developed initially in the lumbar spinal cord and progressed to involve the brainstem and deep cerebellar nuclei. Virions and viral antigens accumulated for 18 weeks postinfection and then declined. Major sites of viral infection outside the CNS were splenic megakaryocytes, and skeletal muscle. Cellular targets of viral replication in the CNS included neurons, oligodendrocytes, and capillary endothelium. No astrocytic infection was observed; however, a reactive gliosis marked the development of clinical symptoms and histopathology. Spongiform lesions began as swelling of perivascular astrocytic processes. Intramyelinic vacuoles with splitting of myelin at major dense lines were prominent around dystrophic axons at later time points. Dendritic processes showed vacuolization and local degeneration. Viral particles were most commonly observed in extracellular spaces and within rough endoplasmic reticulum of neurons, oligodendrocytes, and splenic megakaryocytes. Infected megakaryocytes and regions of spleen containing viral aggregates showed accumulation of ubiquitinated proteins. Areas of histopathology in the CNS showed accumulation of ubiquitinated proteins but unlike spleen, viral proteins were not highly ubiquitinated. Disruption of the blood brain barrier was only evident at late stages of infection. In conclusion, the neuropathogenic damage associated with pNE-8 infection appears to be tightly associated with direct viral infection of oligodendroglia and neurons.


Subject(s)
Brain Diseases/microbiology , Brain/pathology , Retroviridae Infections/pathology , Animals , Antigens, Viral/analysis , Blood-Brain Barrier/physiology , Brain/microbiology , Brain Diseases/pathology , Immunoenzyme Techniques , Leukemia Virus, Murine/immunology , Mice , Mice, Inbred BALB C , Retroviridae Infections/immunology , Spinal Cord/microbiology , Spinal Cord/pathology , Viral Proteins/analysis
13.
Nucl Med Commun ; 12(9): 805-9, 1991 Sep.
Article in English | MEDLINE | ID: mdl-1945192

ABSTRACT

Radionuclide imaging of the lungs with 99Tcm-labelled macroaggregates of human serum albumin (99Tcm-MAA) is a safe, reliable and non-invasive method of diagnosing pulmonary embolism. It has been suggested that following intravenous injection of 99Tcm-MAA, arterial oxygen saturation falls significantly. Oxygen saturation was measured in 101 patients who had received an intravenous injection of 99Tcm-MAA prior to a perfusion lung scan. Readings were taken using a pulse oximeter at rest, immediately following injection, 10, 30 and 60 min post-injection. Twenty-five normal volunteers who were not injected acted as controls. Forty patients showed no change in oxygen saturation throughout the study. A fall of 1% was seen in 32 patients and 2-3% in 26 patients. Of the three patients who demonstrated a reduction in saturation of 6, 7 and 13%, two had chronic airways disease and one had left ventricular failure. Twenty out of 25 normal controls showed no change in saturation over the period of observation. Five showed a fluctuation of 1-2% between the measurements. All patients and controls remained asymptomatic with almost all readings returning to the initial values after 1 h. It was the patients with chest or heart disease who showed a fall in saturation. The study shows that the majority of patients undergoing a perfusion scan with 99Tcm-MAA show no significant fall in oxygen saturation. If a fall occurs, it may be related to the underlying disease process rather than to 99Tcm-MAA.


Subject(s)
Oxygen/blood , Pulmonary Embolism/diagnostic imaging , Technetium Tc 99m Aggregated Albumin/adverse effects , Adult , Aged , Aged, 80 and over , Female , Heart Failure/complications , Humans , Injections, Intravenous , Lung Diseases, Obstructive/complications , Male , Middle Aged , Physical Exertion , Pulmonary Embolism/blood , Pulmonary Embolism/complications , Radionuclide Imaging , Technetium Tc 99m Aggregated Albumin/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...